Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical TrialBusiness Wire • 04/18/23
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)Benzinga • 03/29/23
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsBusiness Wire • 03/15/23
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023Business Wire • 02/17/23
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)PRNewsWire • 11/03/22
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 10/25/22
Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness Wire • 09/07/22
Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseBusiness Wire • 08/17/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/10/22
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from AnthemBusiness Wire • 08/03/22
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 07/26/22
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring SystemBusiness Wire • 06/16/22